10x Genomics Certified Service Provider Program

The University of Michigan Advanced Genomics Core’s mission is to facilitate research in cutting-edge fields of genetics and genomics by implementing complex technologies. Chief among these is “next generation” sequencing (NGS), which has revolutionized research in virtually all biological fields in the past decade. By housing NGS and companion genomic technologies in a single facility, we provide a centralized expertise in advanced methods that enables all researchers to effectively exploit them for making scientific discoveries.

Analytical Biosciences was founded to create and harness the human disease precision atlas through cutting-edge single-cell genomics and bioinformatics, provide integrated and efficient solutions to partners in the biological, clinical and pharmaceutical fields. Now, we had developed several fast and efficient single cell omics analysis methods, established the international advanced single cell omics database and interactive single cell data display platform, and owning a number of single cell biological information technology patents.

The AGCT Core enables investigators with little experience in sample preparation, quality control or analysis to interrogate the genome. To facilitate this, we have developed general but complete wet-lab and bioinformatics analysis pipelines to accommodate standard needs and enable most genomewide investigations. For more sophisticated or custom designs, we work actively in collaboration with other Cedars-Sinai cores and resources to facilitate investigations.

Berry Genomics provides both clinical and research genomic services to the pharmaceutical and academic communities. Their experienced team offers a variety of single-cell services, including 10x Genomics Single Cell RNA-Seq, for which they are 10x Certified.  They also offer 10x Genomics Single Cell ATAC-Seq, 10x Genomics Single Cell V(D)J, 10x Genomics Single Cell CNV and 10x Genomics Visium Spatial Gene Expression Solution using 10x Genomics platforms. Their quick turnaround time, interactive project consultation and data analysis support will enable you to focus on your research. Leave the Single cell sequencing to Berry Genomics' sequencing experts, you will make your discovery faster!

CapitalBio Technology is an industry-leading life science company that develops and commercializes total health-care solutions. Our company provides a comprehensive portfolio of top-quality products to a diverse customer base ranging from biomedical researchers to healthcare professionals. Our products include an innovative and broad spectrum of microarray and microfluidic chips and related instruments, software and databases, reagents and consumables for basic and translational research, drug development, clinical diagnostics, biosafety and food safety, and molecular breeding.

Diamond Age partners with fast-moving biotech and pharmaceutical companies to drive innovation through bioinformatics. They develop and provide custom solutions for the most challenging problems in computational biology. They can also act as a one-stop shop, analyzing existing data (proprietary or public) and helping to answer scientific and strategic questions.   They are led by founder Eleanor Howe, a computational biologist and expert in transcriptional profiling and pathway analysis. Each bioinformatician at Diamond Age has over a decade of experience in the field as well as advanced degrees in life sciences.

HudsonAlpha Discovery supports single cell genomic studies by combining our optimized processes and protocols with technologies from 10x Genomics. We offer single cell RNA-Seq for understanding the transcriptome, CITE-seq to simultaneously assess surface proteins and the transcriptome, ATAC-seq to explore chromatin accessibility, V(D)J B cell receptor sequencing, T cell receptor sequencing as well as nucleic acid isolation, cell sorting, flow cytometry and bioinformatics services.

Established in 2000, DNA Link, Inc. has been maintaining its high-quality NGS services globally. As one of the few NGS labs who maintain CSP-level services for all major NGS platforms, DNA Link has provided breakthrough solution for many challenging genomic analysis projects. From sample preparation to bioinformatics support, DNA Link provides end-to-end solution for any genomic research projects.

Genergy is a wholly-owned subsidiary of NKY Medical Group (Stock code: 300109). We own an integrated CRO service platform, including single cell and spatial research, high-throughput sequencing, and microarray services. We specialize in providing a total solution for scientific ＆ technological services and medical detection.

Geninus, Inc. spin-out of Samsung Genome Institute, provides comprehensive genetic analysis services to empower precision medicine. Their database has both genetic and clinical information to enable clinicians and researchers to promote public health. They lead next generation precision medicine by constructing clinical-genetic information big data. The core proprietary technology is powered by Samsung Genome Institute and is continuously developing by collaborating with Samsung Medical Center and many renowned research institutes around the world.

The Spatial and Single Cell Genomics Platform (S2GP) at Genome Institute of Singapore provides the local research community, with easy access to state-of-the-art single cell capabilities, multi-omics expertise and consultation. The Centre offers multiple 10X and Fluidigm workflows as fee-for-service (ScRNAseq, ScATACseq, Immune profiling (TCR, BCR) and spatial  transcriptome profiling). GIS-S2GP has been functioning as a user friendly, collaborative catalyst in Singapore’s single cell space.

The Genomics Core Facility at the Icahn Institute for Data Science and Genomic Technology and Department of Genetics and Genomic Sciences is a CLIA-certified laboratory, which houses both our basic and translational genomics research. Our researchers leverage cutting-edge technologies and next-generation sequencing capabilities for research and clinical applications. We help investigators and clinicians analyze samples, identify genetic variants contributing to disease risk, and reveal complex mechanisms involved in human disease.

The Imagine Single-Cell platform assists customers from the design of an experiment up to the analyses of single-cell data, with of course single-cell libraries generation and sequencing. The platform will propose all the solutions and protocols commercialized by 10x genomics, with strong expertise in Single-cell gene expression, CITE-seq, ATAC-seq, Immune profiling (TCR, BCR) and the emerging spatial transcriptomic. The Imagine Single-Cell platform is hosted by the Imagine Institute, a leading centre for research, care and teaching on genetic diseases in Europe.

Immunai combines the latest advances in single cell genomics, bioinformatics and artificial intelligence to measure the immune system at high resolution, at unprecedented scale. Our platform pairs these precise immune measurements with relevant clinical context for 1000-patient multi-arm immuno-oncology clinical trials to generate data and insights on mechanisms of action and resistance, biomarkers, combination design, cell therapy product heterogeneity, and more. We partner with leading biopharmas and academic groups to apply our technology and data to drive the development of more effective immunotherapies, and bring these therapies to market more quickly and reliably.

One of our main tasks is to ensure maintenance and transfer of the advanced technological details of DNA sequencing to the future generations. Our additional endeavor is to acquire constantly introduced/modified techniques and methods as well as to develop new techniques and methods of our own. Throughout these activities we aim to create and run a system in which the techniques and methods we use will be offered to scientists in industrial, academic and governmental sectors. Partly based on the royalty we obtain from our clients, we will be able to keep the system continuously running.→ In order to return to the society the knowhow we have acquired through our genomic and genetic analysis over the past 20 years at Kazusa DNA Research Institute, we are planning to provide the society with a system in which advanced technologies for genomic/genetic analysis that require a rather heavy initial investment may be accommodated for the society. In addition to offering commonly used analytical methods within the system, we are happy to announce that users of the system may ask us to help them in performing difficult tasks such as, for example, sequencing degraded or small amounts of DNA/RNA, etc. Until today, using a variety of analytical facilities with sophisticate functions, we have performed a large number of genomic/genetic analyses requested by scientists from industrial, academic and governmental sectors. We will continue to collaborate with scientists of public research institutions as well as those of private sectors by providing them with technical helps and/or contract-based analyses of their samples.

KOTAI Biotechnologies, Inc. is a company offering state-of-the-art research capability to researchers in academia and industries. Our strong research basis has been established through collaborative research projects with top clinical researchers on various disease areas in Japan for years. We are not just a simple service provider but your research partner with deep understandings of your needs.

Macrogen is, a global pioneer in Precision Medicine, dedicated to build the big data with genomic, medical, and lifestyle information, and to innovate the future of medical science by disease prediction. Macrogen has become a global expert in genomic analysis and a leader in Korean biotechnology, working closely with over 18,000 research clients across 153 countries worldwide.

Established in 1996, the Duke University’s Molecular Genomics Core (MGC) is a state of the art facility that has more than 5 years of experience with the 10xGenomics Chromium single cell platform. Through close partnerships with Duke and external Investigators, we have successfully completed more than 80 single cell projects on ~900 sample using gene expression, V(D)J, Cell-hashing, and ATAC-Seq approaches, including the recent multi-omic expression/ATAC-Seq platform. Our facilitation of study design, choice of platform, high quality data generation and integrated analyses have resulted in our collaborators/clients research being published in journals such as Cell, Nature Cell Biology, Nature Immunology, Immunity, amongst others.

Novogene is a leading provider of genomic services and solutions with cutting edge NGS and bioinformatics expertise and the largest sequencing capacity in the world. The company offers 10x Genomics Single Cell RNA-Seq, 10x Genomics Single Cell ATAC-Seq, 10x Genomics Single Cell V(D)J, and 10x Genomics Visium Spatial Gene Expression Solution using 10x Genomics platforms. We are world-leading in NGS services, with thousands of employees and multiple locations across the globe. We are proud to be able to support your research by generating high-quality, publication-ready data in a rapid time-frame. Reach out to us and we will get back to you shortly.

The PMGC is proud to offer one of the largest technology and service portfolios available. We are dedicated to helping you get the most out of your experiment, and will work with you to identify the optimal platform to answer your question.

Proteona is a precision medicine company in Singapore and Germany that is pioneering the use of single cell genetics, genomics and proteomics to improve clinical outcomes in cancer. Using a combination of commercial and proprietary single cell assays with our MapCell suite of bioinformatics tools, Proteona provides a comprehensive sample to answer service that enables users to spend less time trying to understand their data and more time impacting medicine.

Q² Solutions, a leading clinical trial laboratory services organization that provides end-to-end services for Single-cell gene expression, Immune profiling (TCR, BCR), high-throughput sequencing, gene expression profiling and genotyping studies. Our professionals have real-world insight into regulations, customs and sample requirements to help navigate our customer’s products through a global, local or regional trial.

In addition, Q² Solutions provides bioanalytical, vaccines, flow cytometry, anatomic pathology, immunoassay, companion diagnostics and central laboratory services.

Shanghai Baygene Biotechnologies Company Limited is invested by the Hong Kong Gene Group Holdings. They are located in Zizhu National High-Tech Park, Minhang District, Shanghai. They are always committed to scientific and clinical products research and development, manufacturing, sales, technique services and promotion.

Under the leadership of Dr. Cheung To, endowed with professional service philosophy and expertise of Gene Group in the fields of life science, Shanghai Baygene has established professional teams of development and market tech services. Concentrating on keeping up with the frontier of life science, integrating the advanced technology platform and bioinformatics resources, Shanghai Baygene provides a variety of technologies and services for users in the life science field both domestic and abroad, especially Gene-Chip、High-Throughput Genotyping, High-Throughput Sequencing applications and bioinformatics analysis. Apart from the scientific research, Shanghai Baygene also provides solutions for applications in medical science, pharmaceuticals and agriculture and forestry.

Combining expertise across Newcastle University’s core facilities of Genomics, Bioimaging, Bioinformatics and the HDBR, we pleased to be able to offer our SPARTAN service - Spatially Resolved Transcriptomics At Newcastle. Using Visium technology from 10x Genomics, we take your tissue samples through the entire Visium process beginning with sample preparation right the way through to delivery of your results in an easy to interpret and visualise form, ready for immediate analysis. Additionally, human developmental material can be made available for analysis to support your research project.

The Stanford Genomics formerly Stanford Functional Genomics Facility (SFGF) provides services for high-throughput sequencing, single-cell assays, gene expression and genotyping studies utilizing microarray and real-time PCR, and related services to researchers within the Stanford community and to other institutions.

Welgene Biotech provides ISO17025-certificated services on the high-throughput technology platforms such as microarray and next generation sequencing, and drives these technologies into clinical testing or commodities. Welgene continues to co-work with researchers to establish more core technologies, products and business opportunities.